---
figid: PMC8946526__cancers-14-01480-g008
figtitle: 'Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to
  Therapeutic Targeting'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8946526
filename: cancers-14-01480-g008.jpg
figlink: /pmc/articles/PMC8946526/figure/cancers-14-01480-f008/
number: F8
caption: 'Suicide gene strategy for targeting cancer cells expressing constitutively
  stable Fra-1 isoforms. Structure of the lentiviral expression vector containing
  the HSV thymidine kinase gene fused to the Fra-1 C-terminal region (aa. 163–271)
  encompassing the ERK-dependent destabilizer. NLS: Nuclear Localization Signal. The
  lentiviral particles infect both normal and cancer cells, as shown. While in normal
  cells the Fra-1 destabilizer drives the chimeric protein to proteasomal degradation,
  the cancer-associated constitutively active MEK-ERK pathway induces Fra-1 S252/S265
  phosphorylation. Consequently, the tk-Fra-1 fusion protein is protected from proteasomal
  degradation and accumulation. Following ganciclovir treatment, the thymidine kinase-mediated
  transformation of the prodrug causes the accumulation of toxic metabolites blocking
  DNA replication and triggering cell death in phospho-Fra-1-expressing cancer cells,
  while normal cells are spared.'
papertitle: 'The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor
  to Therapeutic Targeting.'
reftext: Laura Casalino, et al. Cancers (Basel). 2022 Mar;14(6):1480.
year: '2022'
doi: 10.3390/cancers14061480
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: transcription factor | AP-1 complex | FOSL1 | Fos-Related-Antigen-1 | therapeutic
  targeting
automl_pathway: 0.9165361
figid_alias: PMC8946526__F8
figtype: Figure
redirect_from: /figures/PMC8946526__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8946526__cancers-14-01480-g008.html
  '@type': Dataset
  description: 'Suicide gene strategy for targeting cancer cells expressing constitutively
    stable Fra-1 isoforms. Structure of the lentiviral expression vector containing
    the HSV thymidine kinase gene fused to the Fra-1 C-terminal region (aa. 163–271)
    encompassing the ERK-dependent destabilizer. NLS: Nuclear Localization Signal.
    The lentiviral particles infect both normal and cancer cells, as shown. While
    in normal cells the Fra-1 destabilizer drives the chimeric protein to proteasomal
    degradation, the cancer-associated constitutively active MEK-ERK pathway induces
    Fra-1 S252/S265 phosphorylation. Consequently, the tk-Fra-1 fusion protein is
    protected from proteasomal degradation and accumulation. Following ganciclovir
    treatment, the thymidine kinase-mediated transformation of the prodrug causes
    the accumulation of toxic metabolites blocking DNA replication and triggering
    cell death in phospho-Fra-1-expressing cancer cells, while normal cells are spared.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tRNA:Glu-CTC-1-1
  - tRNA:Glu-CTC-3-9
  - tRNA:Glu-CTC-2-2
  - tRNA:Glu-CTC-3-6
  - tRNA:Glu-CTC-3-3
  - tRNA:Glu-CTC-3-8
  - tRNA:Glu-CTC-3-4
  - tRNA:Glu-CTC-3-5
  - tRNA:Glu-CTC-3-2
  - tRNA:Glu-CTC-2-3
  - tRNA:Glu-CTC-3-1
  - tRNA:Glu-CTC-2-1
  - tRNA:Glu-CTC-3-7
  - ltr
  - Pgk
  - Dsor1
  - Mtk
  - rl
  - PHGDH
  - FOSL1
  - KRAS
  - NRAS
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
---
